Ocular Complications from Chemotherapeutic Agents -CEW

This is an old revision of the document!

Selumetinib
- Blurred vision, diplopia, eyelid edema, subconjunctival hemorrhage, increased lacrimation, retinal pigment and epithelial detachment

Ocular toxicities of MEK inhibitors and other targeted therapies. Stjepanovic et al. Annals of Oncology.Volume 27, Issue 6, June 2016, Pages 998-1005
Clinical and Morphological Characteristics of MEK Inhibitor-Associated Retinopathy. Francis, Jasmine H. et al. Ophthalmology. 2017-12, Vol.124 (12), p.1788-1798